<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38027145</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2392</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in endocrinology</Title><ISOAbbreviation>Front Endocrinol (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Enteroviral infections are not associated with type 2 diabetes.</ArticleTitle><Pagination><StartPage>1236574</StartPage><MedlinePgn>1236574</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1236574</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fendo.2023.1236574</ELocationID><Abstract><AbstractText Label="INTRODUCTION">For more than a century, enteroviral infections have been associated with autoimmunity and type 1 diabetes (T1D). Uncontrolled viral response pathways repeatedly presented during childhood highly correlate with autoimmunity and T1D. Virus responses evoke chemokines and cytokines, the "cytokine storm" circulating through the body and attack cells especially vulnerable to inflammatory destruction. Intra-islet inflammation is a major trigger of β-cell failure in both T1D and T2D. The genetic contribution of islet inflammation pathways is apparent in T1D, with several mutations in the interferon system. In contrast, in T2D, gene mutations are related to glucose homeostasis in β cells and insulin-target tissue and rarely within viral response pathways. Therefore, the current study evaluated whether enteroviral RNA can be found in the pancreas from organ donors with T2D and its association with disease progression.</AbstractText><AbstractText Label="METHODS">Pancreases from well-characterized 29 organ donors with T2D and 15 age- and BMI-matched controls were obtained from the network for pancreatic organ donors with diabetes and were analyzed in duplicates. Single-molecule fluorescence <i>in-situ</i> hybridization analyses were performed using three probe sets to detect positive-strand enteroviral RNA; pancreas sections were co-stained by classical immunostaining for insulin and CD45.</AbstractText><AbstractText Label="RESULTS">There was no difference in the presence or localization of enteroviral RNA in control nondiabetic and T2D pancreases; viral infiltration showed large heterogeneity in both groups ranging from 0 to 94 virus<sup>+</sup> cells scattered throughout the pancreas, most of them in the exocrine pancreas. Very rarely, a single virus<sup>+</sup> cell was found within islets or co-stained with CD45<sup>+</sup> immune cells. Only one single T2D donor presented an exceptionally high number of viruses, similarly as seen previously in T1D, which correlated with a highly reduced number of β cells.</AbstractText><AbstractText Label="DISCUSSION">No association of enteroviral infection in the pancreas and T2D diabetes could be found. Despite great similarities in inflammatory markers in islets in T1D and T2D, long-term enteroviral infiltration is a distinct pathological feature of T1D-associated autoimmunity and in T1D pancreases.</AbstractText><CopyrightInformation>Copyright © 2023 Liu, Geravandi, Grasso, Sikdar, Pugliese and Maedler.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Huan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centre for Biomolecular Interactions Bremen, University of Bremen, Bremen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The JDRF nPOD-Virus Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Geravandi</LastName><ForeName>Shirin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Biomolecular Interactions Bremen, University of Bremen, Bremen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The JDRF nPOD-Virus Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grasso</LastName><ForeName>Ausilia Maria</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Centre for Biomolecular Interactions Bremen, University of Bremen, Bremen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sikdar</LastName><ForeName>Saheri</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Biomolecular Interactions Bremen, University of Bremen, Bremen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pugliese</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The JDRF nPOD-Virus Group.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Diabetes Research Institute, Department of Medicine, Division of Endocrinology and Metabolism, Miami, FL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Leonard Miller School of Medicine, University of Miami, Miami, FL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Diabetes Immunology &amp; The Wanek Family Project for Type 1 Diabetes, Arthur Riggs Diabetes &amp; Metabolism Research Institute, City of Hope, Duarte, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maedler</LastName><ForeName>Kathrin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Centre for Biomolecular Interactions Bremen, University of Bremen, Bremen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The JDRF nPOD-Virus Group.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Endocrinol (Lausanne)</MedlineTA><NlmUniqueID>101555782</NlmUniqueID><ISSNLinking>1664-2392</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coxsackievirus</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">islets</Keyword><Keyword MajorTopicYN="N">pancreas</Keyword><Keyword MajorTopicYN="N">type 2 diabetes</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>18</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>17</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38027145</ArticleId><ArticleId IdType="pmc">PMC10643152</ArticleId><ArticleId IdType="doi">10.3389/fendo.2023.1236574</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cerasi E, Luft R. Insulin response to glucose infusion in diabetic and non-diabetic monozygotic twin pairs. Genetic control of insulin response? Acta Endocrinol(Copenh) (1967) 55(2):330–45.</Citation><ArticleIdList><ArticleId IdType="pubmed">5338208</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen JH, Dinarello CA, Svenson M. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science (1986) 232(4757):1545–7. doi: 10.1126/science.3086977</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.3086977</ArticleId><ArticleId IdType="pubmed">3086977</ArticleId></ArticleIdList></Reference><Reference><Citation>Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, et al. . Glucose-induced beta-cell production of interleukin-1beta contributes to glucotoxicity in human pancreatic islets. JClinInvest (2002) 110:851–60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC151125</ArticleId><ArticleId IdType="pubmed">12235117</ArticleId></ArticleIdList></Reference><Reference><Citation>Donath MY, Storling J, Maedler K, Mandrup-Poulsen T. Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. JMolMed (2003) 81(8):455–70.</Citation><ArticleIdList><ArticleId IdType="pubmed">12879149</ArticleId></ArticleIdList></Reference><Reference><Citation>Herder C, Baumert J, Thorand B, Koenig W, de Jager W, Meisinger C, et al. . Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002. Diabetologia (2006) 49(5):921–9. doi: 10.1007/s00125-006-0190-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-006-0190-y</ArticleId><ArticleId IdType="pubmed">16532324</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehses JA, Perren A, Eppler E, Ribaux P, Pospisilik JA, Maor-Cahn R, et al. . Increased number of islet-associated macrophages in type 2 diabetes. Diabetes (2007) 56(9):2356–70. doi: 10.2337/db06-1650</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db06-1650</ArticleId><ArticleId IdType="pubmed">17579207</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes (2003) 52(1):102–10. doi: 10.2337/diabetes.52.1.102</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.52.1.102</ArticleId><ArticleId IdType="pubmed">12502499</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams SF. The seasonal variation in the onset of acute diabetes: The age and sex factor in 1,000 diabetic patients. Arch Internal Med (1926) 37:3861. doi: 10.1001/archinte.1926.00120240133010</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.1926.00120240133010</ArticleId></ArticleIdList></Reference><Reference><Citation>Geravandi S, Liu H, Maedler K. Enteroviruses and T1D: is it the virus, the genes or both which cause T1D. Microorganisms (2020) 8(7). doi: 10.3390/microorganisms8071017</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8071017</ArticleId><ArticleId IdType="pmc">PMC7409303</ArticleId><ArticleId IdType="pubmed">32650582</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunne JL, Richardson SJ, Atkinson MA, Craig ME, Dahl-Jorgensen K, Flodstrom-Tullberg M, et al. . Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes. Diabetologia (2019) 62(5):744–53. doi: 10.1007/s00125-019-4811-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-019-4811-7</ArticleId><ArticleId IdType="pmc">PMC6450860</ArticleId><ArticleId IdType="pubmed">30675626</ArticleId></ArticleIdList></Reference><Reference><Citation>Laiho JE, Oikarinen S, Oikarinen M, Larsson PG, Stone VM, Hober D, et al. . Application of bioinformatics in probe design enables detection of enteroviruses on different taxonomic levels by advanced in situ hybridization technology. J Clin Virol (2015) 69:165–71. doi: 10.1016/j.jcv.2015.06.085</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2015.06.085</ArticleId><ArticleId IdType="pubmed">26209400</ArticleId></ArticleIdList></Reference><Reference><Citation>Isaacs SR, Roy A, Dance B, Ward EJ, Foskett DB, Maxwell AJ, et al. . Enteroviruses and risk of islet autoimmunity or type 1 diabetes: systematic review and meta-analysis of controlled observational studies detecting viral nucleic acids and proteins. Lancet Diabetes Endocrinol (2023) 11:578–592. doi: 10.1016/S2213-8587(23)00122-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(23)00122-5</ArticleId><ArticleId IdType="pubmed">37390839</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehik K, Lynch KF, Wong MC, Tian X, Ross MC, Gibbs RA, et al. . Prospective virome analyses in young children at increased genetic risk for type 1 diabetes. Nat Med (2019) 25(12):1865–72. doi: 10.1038/s41591-019-0667-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0667-0</ArticleId><ArticleId IdType="pmc">PMC6898786</ArticleId><ArticleId IdType="pubmed">31792456</ArticleId></ArticleIdList></Reference><Reference><Citation>Faulkner CL, Luo YX, Isaacs S, Rawlinson WD, Craig ME, Kim KW. The virome in early life and childhood and development of islet autoimmunity and type 1 diabetes: A systematic review and meta-analysis of observational studies. Rev Med Virol (2021) 31(5):1–14. doi: 10.1002/rmv.2209</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2209</ArticleId><ArticleId IdType="pmc">PMC8518965</ArticleId><ArticleId IdType="pubmed">33378601</ArticleId></ArticleIdList></Reference><Reference><Citation>Krogvold L, Genoni A, Puggioni A, Campani D, Richardson SJ, Flaxman CS, et al. . Live enteroviruses, but not other viruses, detected in human pancreas at the onset of type 1 diabetes in the DiViD study. Diabetologia (2022) 65(12):2108–20. doi: 10.1007/s00125-022-05779-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-022-05779-2</ArticleId><ArticleId IdType="pmc">PMC9630231</ArticleId><ArticleId IdType="pubmed">35953727</ArticleId></ArticleIdList></Reference><Reference><Citation>Alidjinou EK, Sane F, Engelmann I, Geenen V, Hober D. Enterovirus persistence as a mechanism in the pathogenesis of type 1 diabetes. Discovery Med (2014) 18(100):273–82.</Citation><ArticleIdList><ArticleId IdType="pubmed">25425468</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaidane H, Hober D. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes. Diabetes Metab (2008) 34(6 Pt 1):537–48. doi: 10.1016/j.diabet.2008.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabet.2008.05.008</ArticleId><ArticleId IdType="pubmed">18951821</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyoty H, Leon F, Knip M. Developing a vaccine for type 1 diabetes by targeting coxsackievirus B. Expert Rev Vaccines (2018) 17(12):1071–83. doi: 10.1080/14760584.2018.1548281</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2018.1548281</ArticleId><ArticleId IdType="pubmed">30449209</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendall EK, Olaker VR, Kaelber DC, Xu R, Davis PB. Association of SARS-coV-2 infection with new-onset type 1 diabetes among pediatric patients from 2020 to 2021. JAMA Netw Open (2022) 5(9):e2233014. doi: 10.1001/jamanetworkopen.2022.33014</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.33014</ArticleId><ArticleId IdType="pmc">PMC9508649</ArticleId><ArticleId IdType="pubmed">36149658</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett CE, Koyama AK, Alvarez P, Chow W, Lundeen EA, Perrine CG, et al. . Risk for newly diagnosed diabetes &gt;30 days after SARS-coV-2 infection among persons aged &lt;18 years - United States, march 1, 2020-june 28, 2021. MMWR Morb Mortal Wkly Rep (2022) 71(2):59–65. doi: 10.15585/mmwr.mm7102e2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7102e2</ArticleId><ArticleId IdType="pmc">PMC8757617</ArticleId><ArticleId IdType="pubmed">35025851</ArticleId></ArticleIdList></Reference><Reference><Citation>Rewers M, Bonifacio E, Ewald D, Geno Rasmussen C, Jia X, Pyle L, et al. . SARS-coV-2 infections and presymptomatic type 1 diabetes autoimmunity in children and adolescents from colorado, USA, and bavaria, Germany. Jama (2022) 328(12):1252–5. doi: 10.1001/jama.2022.14092</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.14092</ArticleId><ArticleId IdType="pmc">PMC9356368</ArticleId><ArticleId IdType="pubmed">35930271</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L, She ZG, Cheng X, Qin JJ, Zhang XJ, Cai J, et al. . Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab (2020) 31(6):1068–77 e3. doi: 10.1016/j.cmet.2020.04.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.04.021</ArticleId><ArticleId IdType="pmc">PMC7252168</ArticleId><ArticleId IdType="pubmed">32369736</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefan N, Birkenfeld AL, Schulze MB. Global pandemics interconnected - obesity, impaired metabolic health and COVID-19. Nat Rev Endocrinol (2021) 17(3):135–49. doi: 10.1038/s41574-020-00462-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-020-00462-1</ArticleId><ArticleId IdType="pubmed">33479538</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauvais-Jarvis F. Aging, male sex, obesity, and metabolic inflammation create the perfect storm for COVID-19. Diabetes (2020) 69(9):1857–63. doi: 10.2337/dbi19-0023</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dbi19-0023</ArticleId><ArticleId IdType="pmc">PMC7458034</ArticleId><ArticleId IdType="pubmed">32669390</ArticleId></ArticleIdList></Reference><Reference><Citation>Geravandi S, Mahmoudi-Aznaveh A, Azizi Z, Maedler K, Ardestani A. SARS-CoV-2 and pancreas: a potential pathological interaction? Trends Endocrinol Metab (2021) 32(11):842–5. doi: 10.1016/j.tem.2021.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2021.07.004</ArticleId><ArticleId IdType="pmc">PMC8302839</ArticleId><ArticleId IdType="pubmed">34373155</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehses JA, Ellingsgaard H, Boni-Schnetzler M, Donath MY. Pancreatic islet inflammation in type 2 diabetes: from alpha and beta cell compensation to dysfunction. Arch Physiol Biochem (2009) 115(4):240–7. doi: 10.1080/13813450903025879</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13813450903025879</ArticleId><ArticleId IdType="pubmed">19645635</ArticleId></ArticleIdList></Reference><Reference><Citation>Donath MY. Targeting inflammation in the treatment of type 2 diabetes: time to start. Nat Rev Drug Discovery (2014) 13(6):465–76. doi: 10.1038/nrd4275</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd4275</ArticleId><ArticleId IdType="pubmed">24854413</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuenco J, Dalmas E. Islet inflammation and beta cell dysfunction in type 2 diabetes. Handb Exp Pharmacol (2022) 274:227–51. doi: 10.1007/164_2021_571</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/164_2021_571</ArticleId><ArticleId IdType="pubmed">35044537</ArticleId></ArticleIdList></Reference><Reference><Citation>Blencowe M, Furterer A, Wang Q, Gao F, Rosenberger M, Pei L, et al. . IAPP-induced beta cell stress recapitulates the islet transcriptome in type 2 diabetes. Diabetologia (2022) 65(1):173–87. doi: 10.1007/s00125-021-05569-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-021-05569-2</ArticleId><ArticleId IdType="pmc">PMC8660728</ArticleId><ArticleId IdType="pubmed">34554282</ArticleId></ArticleIdList></Reference><Reference><Citation>Maedler K, Sergeev P, Ehses JA, Mathe Z, Bosco D, Berney T, et al. . Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets. Proc Natl Acad Sci U S A (2004) 101(21):8138–43. doi: 10.1073/pnas.0305683101</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0305683101</ArticleId><ArticleId IdType="pmc">PMC419570</ArticleId><ArticleId IdType="pubmed">15141093</ArticleId></ArticleIdList></Reference><Reference><Citation>Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, et al. . Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest (2017) 127(4):1589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5373884</ArticleId><ArticleId IdType="pubmed">28368291</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthess FT, Paroni F, Sauter NS, Shu L, Ribaux P, Haataja L, et al. . CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling. Cell Metab (2009) 9(2):125–39. doi: 10.1016/j.cmet.2009.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2009.01.003</ArticleId><ArticleId IdType="pubmed">19187771</ArticleId></ArticleIdList></Reference><Reference><Citation>Westwell-Roper C, Nackiewicz D, Dan M, Ehses JA. Toll-like receptors and NLRP3 as central regulators of pancreatic islet inflammation in type 2 diabetes. Immunol Cell Biol (2014) 92(4):314–23. doi: 10.1038/icb.2014.4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.2014.4</ArticleId><ArticleId IdType="pubmed">24492799</ArticleId></ArticleIdList></Reference><Reference><Citation>Westwell-Roper CY, Chehroudi CA, Denroche HC, Courtade JA, Ehses JA, Verchere CB. IL-1 mediates amyloid-associated islet dysfunction and inflammation in human islet amyloid polypeptide transgenic mice. Diabetologia (2015) 58(3):575–85. doi: 10.1007/s00125-014-3447-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-014-3447-x</ArticleId><ArticleId IdType="pubmed">25491100</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen AA, Gannon M. The beta cell in type 2 diabetes. Curr Diabetes Rep (2019) 19(9):81. doi: 10.1007/s11892-019-1196-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-019-1196-4</ArticleId><ArticleId IdType="pubmed">31399863</ArticleId></ArticleIdList></Reference><Reference><Citation>Moin ASM, Butler AE. Alterations in beta cell identity in type 1 and type 2 diabetes. Curr Diabetes Rep (2019) 19(9):83. doi: 10.1007/s11892-019-1194-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-019-1194-6</ArticleId><ArticleId IdType="pmc">PMC6689286</ArticleId><ArticleId IdType="pubmed">31401713</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellingsgaard H, Ehses JA, Hammar EB, Van Lommel L, Quintens R, Martens G, et al. . Interleukin-6 regulates pancreatic alpha-cell mass expansion. Proc Natl Acad Sci U S A (2008) 105(35):13163–8. doi: 10.1073/pnas.0801059105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0801059105</ArticleId><ArticleId IdType="pmc">PMC2529061</ArticleId><ArticleId IdType="pubmed">18719127</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajendran S, Quesada-Masachs E, Zilberman S, Graef M, Kiosses WB, Chu T, et al. . IL-17 is expressed on beta and alpha cells of donors with type 1 and type 2 diabetes. J Autoimmun (2021) 123:102708. doi: 10.1016/j.jaut.2021.102708</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102708</ArticleId><ArticleId IdType="pmc">PMC8386282</ArticleId><ArticleId IdType="pubmed">34358764</ArticleId></ArticleIdList></Reference><Reference><Citation>Donath MY, Boni-Schnetzler M, Ellingsgaard H, Ehses JA. Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes. Physiol (Bethesda) (2009) 24:325–31.</Citation><ArticleIdList><ArticleId IdType="pubmed">19996363</ArticleId></ArticleIdList></Reference><Reference><Citation>Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol (2011) 11(2):98–107. doi: 10.1038/nri2925</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2925</ArticleId><ArticleId IdType="pubmed">21233852</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CL, Sun F, Wang FX, Rong SJ, Yue TT, Luo JH, et al. . The interferon regulatory factors, a double-edged sword, in the pathogenesis of type 1 diabetes. Cell Immunol (2022) 379:104590. doi: 10.1016/j.cellimm.2022.104590</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2022.104590</ArticleId><ArticleId IdType="pubmed">36030565</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler C, Lauber C, Adler K, Grallert H, Illig T, Ziegler AG, et al. . An interferon-induced helicase (IFIH1) gene polymorphism associates with different rates of progression from autoimmunity to type 1 diabetes. Diabetes (2011) 60(2):685–90. doi: 10.2337/db10-1269</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db10-1269</ArticleId><ArticleId IdType="pmc">PMC3028371</ArticleId><ArticleId IdType="pubmed">21270278</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin M, Zhang Y, Liu S, Huang J, Li X. Gene expression signatures reveal common virus infection pathways in target tissues of type 1 diabetes, hashimoto’s thyroiditis, and celiac disease. Front Immunol (2022) 13:891698. doi: 10.3389/fimmu.2022.891698</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.891698</ArticleId><ArticleId IdType="pmc">PMC9251511</ArticleId><ArticleId IdType="pubmed">35795668</ArticleId></ArticleIdList></Reference><Reference><Citation>Szymczak F, Colli ML, Mamula MJ, Evans-Molina C, Eizirik DL. Gene expression signatures of target tissues in type 1 diabetes, lupus erythematosus, multiple sclerosis, and rheumatoid arthritis. Sci Adv (2021) 7(2). doi: 10.1126/sciadv.abd7600</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abd7600</ArticleId><ArticleId IdType="pmc">PMC7787485</ArticleId><ArticleId IdType="pubmed">33523973</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan A, Spracklen CN, Zhang W, Ng MCY, Petty LE, Kitajima H, et al. . Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. Nat Genet (2022) 54(5):560–72. doi: 10.1038/s41588-022-01058-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01058-3</ArticleId><ArticleId IdType="pmc">PMC9179018</ArticleId><ArticleId IdType="pubmed">35551307</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagafuchi S, Kamada-Hibio Y, Hirakawa K, Tsutsu N, Minami M, Okada A, et al. . TYK2 promoter variant and diabetes mellitus in the Japanese. EBioMedicine (2015) 2(7):744–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4534683</ArticleId><ArticleId IdType="pubmed">26288847</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori H, Takahashi H, Mine K, Higashimoto K, Inoue K, Kojima M, et al. . TYK2 promoter variant is associated with impaired insulin secretion and lower insulin resistance in Japanese type 2 diabetes patients. Genes (Basel) (2021) 12(3).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7999758</ArticleId><ArticleId IdType="pubmed">33799705</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard H, Teijeiro A, Chaves-Perez A, Perna C, Satish B, Novials A, et al. . Coxsackievirus B Type 4 Infection in beta Cells Downregulates the Chaperone Prefoldin URI to Induce a MODY4-like Diabetes via Pdx1 Silencing. Cell Rep Med (2020) 1(7):100125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7659558</ArticleId><ArticleId IdType="pubmed">33205075</ArticleId></ArticleIdList></Reference><Reference><Citation>Gkrania-Klotsas E, Langenberg C, Tauriainen S, Sharp SJ, Luben R, Forouhi NG, et al. . The association between prior infection with five serotypes of Coxsackievirus B and incident type 2 diabetes mellitus in the EPIC-Norfolk study. Diabetologia (2012) 55:967–70.</Citation><ArticleIdList><ArticleId IdType="pubmed">22231126</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia (2009) 52(6):1143–51.</Citation><ArticleIdList><ArticleId IdType="pubmed">19266182</ArticleId></ArticleIdList></Reference><Reference><Citation>Geravandi S, Richardson S, Pugliese A, Maedler K. Localization of enteroviral RNA within the pancreas in donors with T1D and T1D-associated autoantibodies. Cell Rep Med (2021) 2(8):100371.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8385321</ArticleId><ArticleId IdType="pubmed">34467248</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaddis JS, Pugliese A, Atkinson MA. A run on the biobank: what have we learned about type 1 diabetes from the nPOD tissue repository? Curr Opin Endocrinol Diabetes Obes (2015) 22(4):290–5. doi: 10.1097/MED.0000000000000171</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MED.0000000000000171</ArticleId><ArticleId IdType="pubmed">26087339</ArticleId></ArticleIdList></Reference><Reference><Citation>Busse N, Paroni F, Richardson SJ, Laiho JE, Oikarinen M, Frisk G, et al. . Detection and localization of viral infection in the pancreas of patients with type 1 diabetes using short fluorescently-labelled oligonucleotide probes. Oncotarget (2017) 8(8):12620–36. doi: 10.18632/oncotarget.14896</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.14896</ArticleId><ArticleId IdType="pmc">PMC5355040</ArticleId><ArticleId IdType="pubmed">28147344</ArticleId></ArticleIdList></Reference><Reference><Citation>Skog O, Ingvast S, Korsgren O. Evaluation of RT-PCR and immunohistochemistry as tools for detection of enterovirus in the human pancreas and islets of Langerhans. J Clin Virol (2014) 61(2):242–7. doi: 10.1016/j.jcv.2014.07.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2014.07.014</ArticleId><ArticleId IdType="pmc">PMC4165708</ArticleId><ArticleId IdType="pubmed">25132399</ArticleId></ArticleIdList></Reference><Reference><Citation>Butcher MJ, Hallinger D, Garcia E, Machida Y, Chakrabarti S, Nadler J, et al. . Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes. Diabetologia (2014) 57(3):491–501. doi: 10.1007/s00125-013-3116-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-013-3116-5</ArticleId><ArticleId IdType="pmc">PMC3966210</ArticleId><ArticleId IdType="pubmed">24429578</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunemaker CS. Considerations for defining cytokine dose, duration, and milieu that are appropriate for modeling chronic low-grade inflammation in type 2 diabetes. J Diabetes Res (2016) 2016:2846570. doi: 10.1155/2016/2846570</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/2846570</ArticleId><ArticleId IdType="pmc">PMC5097812</ArticleId><ArticleId IdType="pubmed">27843953</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordmann TM, Dror E, Schulze F, Traub S, Berishvili E, Barbieux C, et al. . The role of inflammation in beta-cell dedifferentiation. Sci Rep (2017) 7(1):6285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5524956</ArticleId><ArticleId IdType="pubmed">28740254</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell-Thompson ML, Atkinson MA, Butler AE, Chapman NM, Frisk G, Gianani R, et al. . The diagnosis of insulitis in human type 1 diabetes. Diabetologia (2013) 56(11):2541–3. doi: 10.1007/s00125-013-3043-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-013-3043-5</ArticleId><ArticleId IdType="pubmed">24006089</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Calvo T, Richardson SJ, Pugliese A. Pancreas pathology during the natural history of type 1 diabetes. Curr Diabetes Rep (2018) 18(11):124. doi: 10.1007/s11892-018-1084-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-018-1084-3</ArticleId><ArticleId IdType="pubmed">30293191</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson J, Krisky D, Casas R, Battelino T, Castano L, Greening J, et al. . GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus. N Engl J Med (2012) 366(5):433–42. doi: 10.1056/NEJMoa1107096</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1107096</ArticleId><ArticleId IdType="pubmed">22296077</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr ALJ, Perry DJ, Lynam AL, Chamala S, Flaxman CS, Sharp SA, et al. . Histological validation of a type 1 diabetes clinical diagnostic model for classification of diabetes. Diabetes Med (2020) 37(12):2160–2168. doi: 10.1111/dme.14361</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dme.14361</ArticleId><ArticleId IdType="pmc">PMC8086995</ArticleId><ArticleId IdType="pubmed">32634859</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj A, van den Bogaard P, Rifkin SA, van Oudenaarden A, Tyagi S. Imaging individual mRNA molecules using multiple singly labeled probes. Nat Methods (2008) 5(10):877–9. doi: 10.1038/nmeth.1253</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1253</ArticleId><ArticleId IdType="pmc">PMC3126653</ArticleId><ArticleId IdType="pubmed">18806792</ArticleId></ArticleIdList></Reference><Reference><Citation>Farack L, Golan M, Egozi A, Dezorella N, Bahar Halpern K, Ben-Moshe S, et al. . Transcriptional heterogeneity of beta cells in the intact pancreas. Dev Cell (2019) 48(1):115–25 e4. doi: 10.1016/j.devcel.2018.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2018.11.001</ArticleId><ArticleId IdType="pubmed">30503750</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson SF, Korsgren S, Ponten F, Korsgren O. Enteroviruses and the pathogenesis of type 1 diabetes revisited: cross-reactivity of enterovirus capsid protein (VP1) antibodies with human mitochondrial proteins. J Pathol (2013) 229(5):719–28. doi: 10.1002/path.4166</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.4166</ArticleId><ArticleId IdType="pubmed">23335350</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer P, Pirozzi NM, Wolters AHG, Kuipers J, Kusmartseva I, Atkinson MA, et al. . Large-scale electron microscopy database for human type 1 diabetes. Nat Commun (2020) 11(1):2475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7235089</ArticleId><ArticleId IdType="pubmed">32424134</ArticleId></ArticleIdList></Reference><Reference><Citation>Huising MO, Lee S, van der Meulen T. Evidence for a neogenic niche at the periphery of pancreatic islets. Bioessays (2018) 40(11):e1800119. doi: 10.1002/bies.201800119</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.201800119</ArticleId><ArticleId IdType="pmc">PMC6570402</ArticleId><ArticleId IdType="pubmed">30264410</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Meulen T, Mawla AM, DiGruccio MR, Adams MW, Nies V, Dolleman S, et al. . Virgin Beta Cells Persist throughout Life at a Neogenic Niche within Pancreatic Islets. Cell Metab (2017) 25(4):911–26 e6. doi: 10.1016/j.cmet.2017.03.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2017.03.017</ArticleId><ArticleId IdType="pmc">PMC8586897</ArticleId><ArticleId IdType="pubmed">28380380</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorrell C, Schug J, Canaday PS, Russ HA, Tarlow BD, Grompe MT, et al. . Human islets contain four distinct subtypes of beta cells. Nat Commun (2016) 7:11756. doi: 10.1038/ncomms11756</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11756</ArticleId><ArticleId IdType="pmc">PMC4942571</ArticleId><ArticleId IdType="pubmed">27399229</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharmadhikari G, Stolz K, Hauke M, Morgan NG, Varki A, de Koning E, et al. . Siglec-7 restores beta-cell function and survival and reduces inflammation in pancreatic islets from patients with diabetes. Sci Rep (2017) 7:45319. doi: 10.1038/srep45319</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep45319</ArticleId><ArticleId IdType="pmc">PMC5381285</ArticleId><ArticleId IdType="pubmed">28378743</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshima M, Knoch KP, Diedisheim M, Petzold A, Cattan P, Bugliani M, et al. . Virus-like infection induces human beta cell dedifferentiation. JCI Insight (2018) 3(3). doi: 10.1172/jci.insight.97732</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.97732</ArticleId><ArticleId IdType="pmc">PMC5821176</ArticleId><ArticleId IdType="pubmed">29415896</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello A, Farzaneh F, Candore G, Caruso C, Davinelli S, Gambino CM, et al. . Immunosenescence and its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention. Front Immunol (2019) 10:2247. doi: 10.3389/fimmu.2019.02247</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02247</ArticleId><ArticleId IdType="pmc">PMC6773825</ArticleId><ArticleId IdType="pubmed">31608061</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouin A, Vu MN, Al-Hakeem A, Tran GP, Nguyen JHC, Semler BL. Enterovirus-cardiomyocyte interactions: impact of terminally deleted genomic RNAs on viral and host functions. J Virol (2022):e0142622. doi: 10.1101/2022.09.15.508200</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.09.15.508200</ArticleId><ArticleId IdType="pmc">PMC9888282</ArticleId><ArticleId IdType="pubmed">36475766</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh T, Sarmiento L, Luan C, Prasad RB, Johansson J, Cataldo LR, et al. . MafA expression preserves immune homeostasis in human and mouse islets. Genes (Basel) (2018) 9(12). doi: 10.3390/genes9120644</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes9120644</ArticleId><ArticleId IdType="pmc">PMC6315686</ArticleId><ArticleId IdType="pubmed">30567413</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>